Organ-Specific Supportive Measures for Critical Conditions
For patients with sepsis, DIC, and related critical conditions, adjunctive organ-specific supportive measures should include anticoagulant therapy for coagulopathy, hemodynamic support targeting mean arterial pressure of 65-70 mmHg while avoiding fluid overload, and antioxidant therapy to mitigate oxidative stress damage. 1
Hemodynamic Support
Fluid Management
- Crystalloid solutions should be first-line therapy for volume resuscitation 2
- Target a mean arterial pressure of 65-70 mmHg 2
- Avoid fluid overload which can:
- Aggravate gut edema
- Increase intra-abdominal pressure
- Lead to abdominal compartment syndrome 2
Vasopressor Support
- Implement after adequate fluid resuscitation
- Monitor for signs of increased intra-abdominal pressure which may reduce regional and global perfusion 2
Coagulation Support for DIC
Diagnostic Approach
- Use a two-step diagnostic process:
Anticoagulant Therapy
- Consider recombinant thrombomodulin in septic patients with DIC (21.4% mortality vs. 31.6% with heparin) 1
- Heparin therapy (unfractionated or low-molecular-weight) may help prevent purpura fulminans and symmetrical peripheral gangrene 1
- Antithrombin supplementation may benefit septic patients with DIC who have decreased antithrombin activity 2
Monitoring
- Daily assessment of coagulation parameters:
- Platelet count
- PT/INR
- Fibrinogen
- D-dimer 1
- Regularly reassess SIC and DIC scores to guide ongoing therapy
Kidney Function Support
- Maintain adequate renal perfusion through appropriate fluid management and hemodynamic support
- Avoid nephrotoxic agents when possible
- Monitor for acute kidney injury through:
- Urine output
- Serum creatinine
- Blood urea nitrogen
Mitigation of Oxidative Stress
Antioxidant Therapy
- Oxidative stress significantly contributes to organ dysfunction in sepsis 4, 5
- Multiple antioxidant agents may act additively or synergistically on different pathways 4
Specific Antioxidant Considerations
- N-acetylcysteine may help replenish glutathione stores and combat oxidative stress
- Coenzyme Q10 supports mitochondrial function and may reduce oxidative damage
- Selenium has been studied in sepsis with some potential benefit, though more clinical trials are needed 2
- One small randomized controlled trial showed reduction in 28-day mortality with high-dose selenium (1000 μg daily over 15 days) 2
Nutritional Support
- Early enteral nutrition is preferred when possible 2
- Avoid immunoenhancing enteral formulations in patients with severe sepsis and APACHE II scores >25 2
- Maintain blood glucose levels ≤8.3 mmol/L (150 mg/dL) 2
- Do not aim for strictly normal blood glucose levels of 4.4-6.6 mmol/L (80-120 mg/dL) as this may increase mortality and hypoglycemic events 2
Adjunctive Measures
DVT Prophylaxis
- Essential in septic patients due to consumption coagulopathy increasing risk of venous clots 2
- Use subcutaneous heparin or low molecular weight heparin unless contraindicated 2
Stress Ulcer Prophylaxis
- Important in septic patients due to increased risk of stress ulcers 2
Monitoring and Complications
- Watch for bleeding complications in patients receiving anticoagulant therapy
- Monitor for symmetrical peripheral gangrene, a devastating complication of sepsis and DIC 1
- Assess for signs of multiorgan dysfunction regularly
Remember that while these organ-specific supportive measures are important adjuncts, controlling the underlying infection with appropriate antimicrobial therapy and source control remains the cornerstone of treatment for sepsis and related conditions.